The Lundbeck Foundation Center for Biomembranes in Nanomedicine (CBN) is a Lundbeck Foundation Center of Excellence established at the Department of Neuroscience and Pharmacology, at the Faculty of Health Sciences, and will run from 2010 to 2015.
Center Mission
The mission of the CBN is to employ novel nanoscale technologies to investigate critical protein-membrane and membrane-membrane interactions controlling signal transmission across biological membranes. The Centre focuses on neuronal and prokaryotic cell-to-cell signaling, and the systems studied include G protein coupled receptors, ion-coupled transporters (neurotransmitters) as well as vesicle exocytosis and endocytosis.
The insights gained from these investigations will form the basis for the subsequent development of prototypical nano-biosensors and design of membrane nanocontainers for drug delivery.
The Center brings together an interdisciplinary team of experts in biophysics, biochemistry, bioorganic chemistry, molecular and cellular biology, employing a wide range of new nanoscale technologies to study membrane processes in a quantitative manner and down to the single molecule level.